New precision approach against coronavirus infection

The picture represents the most stable configuration of the interaction between human ACE2 (green) with the aptamer able to block the interaction with SARS-CoV-2
Credits: Ciana (Università degli Studi di Milano). Source: IIT, Scuola Superiore Sant'Anna, Università degli Studi di Milano

How the ACE2 receptor blocks the ‘gateway’ into human cells.

A new precision strategy to hinder the infection of the coronavirus and its rapid spread between cells will come from Italian scientific research, destined to be the basis of a new drug, for which a patent has already been filed.

The road that will lead to the drug has started from the study sponsored by the Istituto Italiano di Tecnologia (Italian Institute of Technology), Scuola Superiore Sant’Anna (Sant’Anna School), University of Milan, now published in the journal Pharmacological Research, organ of the “International Union of Basic and Clinical Pharmacology”.

Scientists Paolo Ciana (University of Milan, Professor of Pharmacology), Vincenzo Lionetti (Scuola Superiore Sant’Anna, Professor of Anesthesiology), Angelo Reggiani (Italian Institute of Technology, Senior Researcher and Principal Investigator in Pharmacology) have wondered about the possibility of preventing the progressive advancement of infection by any variant of Sars-CoV-2, blocking the ACE2 receptor, the “door” that the coronavirus uses to enter human cells. For this purpose, the scientists have patented a new approach, the first piece of what will become a drug, based on the use of a DNA aptamer, a short oligonucleotide strand, able to bind specifically to residue K353 of ACE2 making it inaccessible to the spike protein of any coronavirus.

The three inventors, together with collaborators, have already identified two anti-K353 aptamers, those capable of dose-dependently inhibiting the binding of the viral spike protein to human ACE2 and thus effectively preventing cell infection.

“Thanks to this study, it will now be possible to develop a new precision therapeutic approach to prevent Covid-19 infection in a severe form, without stimulating the immune system or having important side effects related to the most popular drugs consisting of monoclonal antibodies or other therapeutic proteins. In this sense, in fact, the potential toxicities of nucleic acids as drugs are far less than other innovative drugs such as monoclonal antibodies or other therapeutic proteins”, they commented.

Journal: Pharmacological Research
DOI: 10.1016/j.phrs.2021.105982
Method of Research: Experimental study
Subject of Research: Cells
Article Title: DNA aptamers masking angiotensin converting enzyme 2 as an innovative way to treat SARS-CoV-2 pandemic.
Article Publication Date: 16-Nov-2021

Media Contact

Valeria delle Cave
Istituto Italiano di Tecnologia – IIT
valeria.dellecave@iit.it
Office: 0039 010 2896

www.iit.it

Media Contact

Valeria delle Cave
Istituto Italiano di Tecnologia - IIT

All latest news from the category: Life Sciences and Chemistry

Articles and reports from the Life Sciences and chemistry area deal with applied and basic research into modern biology, chemistry and human medicine.

Valuable information can be found on a range of life sciences fields including bacteriology, biochemistry, bionics, bioinformatics, biophysics, biotechnology, genetics, geobotany, human biology, marine biology, microbiology, molecular biology, cellular biology, zoology, bioinorganic chemistry, microchemistry and environmental chemistry.

Back to home

Comments (0)

Write a comment

Newest articles

Perovskite solar cells soar to new heights

Metal halide perovskites have been under intense investigation over the last decade, due to the remarkable rise in their performance in optoelectronic devices such as solar cells or light-emitting diodes….

Blue hydrogen can help protect the climate

An international group of researchers led by the Paul Scherrer Institute and the Heriot-Watt University has carried out in-depth analyses of the climate impact of blue hydrogen. This is produced…

Genes associated with hearing loss visualised in new study

Researchers from Uppsala University have been able to document and visualise hearing loss-associated genes in the human inner ear, in a unique collaboration study between otosurgeons and geneticists. The findings…

Partners & Sponsors